Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedLocations section now lists Massachusetts as a study site. The older Massachusetts Locations entry and the HHS Vulnerability Disclosure were removed, and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedPublication notes were updated to clarify that publications are provided voluntarily by the person entering information and pertain to the study results. The revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the government funding status notice; study details and links remain unchanged.SummaryDifference0.4%

- Check68 days agoChange DetectedNon-significant changes observed: The two screenshots show largely the same Study Details page with no core information added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check97 days agoChange DetectedUpdated to v3.2.0 with an operational status notice; removed a specific disease resource (Cutaneous neuroendocrine carcinoma) and v3.1.0 reference.SummaryDifference4%

- Check104 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.